For example, in the study of Alpiniae oxyphyllae Fructus against hyperuricemia, molecular docking suggested that active ingredients could bind to targets such as PPARG, ESR1, PTGS2, and HMGCR, potentially mediating therapeutic effects on immune and inflammatory responses. The gene discussed is HMGCR; the disease is hyperuricemia.